About Ganymed Pharmaceuticals AG
Available information shows that Ganymed Pharmaceuticals AG operates in the Life Science sector. The company is headquartered in Mainz. The company is classified under the Life Science sector.
Acquired
Ganymed Pharmaceuticals AG
acquired by Astellas Pharma, Inc. in 2016
1
Transactions
Sign up to view
$422M
Deal Value
Sign up to view
Investors
Current Investors
Astellas Pharma, Inc.
••••••••
Past Investors
••••••••
••••••••
Investment Details
1 Transactions
| Trans. ID | Investment Date | Exit Date | Investor(s) | Deal Size (M) | Seller(s) |
|---|---|---|---|---|---|
Ganymed Pharmaceuticals AG M&A Activity
| # | Company | Transaction Date | Close Date | Sector | Country |
|---|---|---|---|---|---|
|
|
|||||
|
|
|||||
|
|
|||||
|
|
Key Executives & Professionals
Frequently Asked Questions
What does Ganymed Pharmaceuticals AG do?
Available information shows that Ganymed Pharmaceuticals AG operates in the Life Science sector. The company is headquartered in Mainz. The company is classified under the Life Science sector.
Where is Ganymed Pharmaceuticals AG headquartered?
Ganymed Pharmaceuticals AG is headquartered in Mainz, Germany.
When was Ganymed Pharmaceuticals AG founded?
Founded year information for Ganymed Pharmaceuticals AG is available on AcquityData.
What sector is Ganymed Pharmaceuticals AG in?
Ganymed Pharmaceuticals AG operates in the Life Science sector.
Who are the investors in Ganymed Pharmaceuticals AG?
Current investors in Ganymed Pharmaceuticals AG include Astellas Pharma, Inc.. Sign up to AcquityData to view full investor details, deal dates and transaction history.
How many M&A transactions has Ganymed Pharmaceuticals AG been involved in?
Ganymed Pharmaceuticals AG has 1 transaction tracked on AcquityData. Sign up to view full investment history including dates, deal sizes, investors and sellers.
Unlock the full Ganymed Pharmaceuticals AG profile
Ownership & Investors
M&A History
Financials
Key Executives
Advisors & Lenders
Access Ganymed Pharmaceuticals AG's complete ownership history, M&A activity, investors, advisors and executives in one connected platform.
Start Free Trial